MoneyWorks4Me

Aurobindo Pharma - Quaterly Results

10 Aug 2024 Evaluate
A minor change in the total revenue was seen in the June 2024 quarter. The total revenue for the quarter stood at Rs. 24600.90 millions against Rs. 23908.20 millions during year ago period.Net profit showed a marginal rise at Rs. 3290.40 millions for the quarter ended June 2024, as compared to corresponding quarter of last year.Operating Profit saw a handsome growth to 5642.50 millions from 5176.60 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 24600.90 23908.20 2.90 24600.90 23908.20 2.90 106456.40 84570.00 25.88
Other Income 653.20 953.40 -31.49 653.20 953.40 -31.49 6160.60 4439.20 38.78
PBIDT 5642.50 5176.60 9.00 5642.50 5176.60 9.00 28401.00 19488.30 45.73
Interest 511.30 315.90 61.86 511.30 315.90 61.86 1826.00 745.80 144.84
PBDT 5131.20 4860.70 5.57 5131.20 4860.70 5.57 26575.00 18742.50 41.79
Depreciation 668.80 596.30 12.16 668.80 596.30 12.16 2545.80 2432.60 4.65
PBT 4462.40 4264.40 4.64 4462.40 4264.40 4.64 24029.20 16309.90 47.33
TAX 1172.00 1081.20 8.40 1172.00 1081.20 8.40 5028.20 3888.20 29.32
Deferred Tax -24.60 -82.60 -70.22 -24.60 -82.60 -70.22 -952.60 -233.40 308.14
PAT 3290.40 3183.20 3.37 3290.40 3183.20 3.37 19001.00 12421.70 52.97
Equity 585.90 585.90 0.00 585.90 585.90 0.00 585.90 585.90 0.00
PBIDTM(%) 22.94 21.65 5.93 22.94 21.65 5.93 26.68 23.04 15.77
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..